Mohammed A. Omair

ORCID: 0000-0002-9373-5473
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Systemic Sclerosis and Related Diseases
  • Biosimilars and Bioanalytical Methods
  • Health Systems, Economic Evaluations, Quality of Life
  • Autoimmune and Inflammatory Disorders Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Chronic Lymphocytic Leukemia Research
  • Cytokine Signaling Pathways and Interactions
  • Inflammatory Myopathies and Dermatomyositis
  • Salivary Gland Disorders and Functions
  • Lymphoma Diagnosis and Treatment
  • Vasculitis and related conditions
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Pharmaceutical Economics and Policy
  • Atherosclerosis and Cardiovascular Diseases
  • Spondyloarthritis Studies and Treatments
  • Clinical practice guidelines implementation
  • COVID-19 and Mental Health
  • T-cell and B-cell Immunology
  • Musculoskeletal pain and rehabilitation
  • Autoimmune Bullous Skin Diseases
  • Toxin Mechanisms and Immunotoxins
  • Ocular Diseases and Behçet’s Syndrome
  • Sarcoidosis and Beryllium Toxicity Research

King Saud University
2016-2025

King Saud Medical City
2019-2025

Saudi Aramco Medical Services Organization
2024

King Fahad Specialist Hospital
2024

Taibah University
2024

King Abdullah Medical City
2023

Central Laboratory For Agricultural Expert Systems
2023

Princess Nourah bint Abdulrahman University
2021-2023

University of Sharjah
2021-2023

Weatherford College
2023

Andrew D. Dick James T. Rosenbaum Hassan Al-Dhibi Rubens Belfort Antoine P. Brézin and 95 more Soon‐Phaik Chee Janet L. Davis Athimalaipet V Ramanan Koh‐Hei Sonoda Ester Carreño Heloísa Nascimento S. Ben Salah Sherveen Salek Jay Siak Laura R Steeples Massimo Accorinti Nisha R. Acharya Alfredo Adán Rupesh Agrawal Nurullah Akkoç Saed Al Ghamdi Turki Al Ghamdi Anood Al Saati Nasser Alsabaani Mohamed Al-Shamarani Artur Bachta Talin Barisani‐Asenbauer Nicholas A. V. Beare Fernanda Belga Ottoni Porto Ricardo Blanco Anita Chan Sook Yee Vinod Chandran Christophe Chiquet Hiok Hee Chng Andrius Cimbalas Luca Cimino Miguel Cordero‐Coma C. Blanco Cristóbal Miguel Cuevas João Eurico da Fonseca Joke de Boer Alejandra de‐la‐Torre Ilse De Schryver Larissa Derzko-Dzulynsky David Díaz‐Valle Claudia Eugenia Duran Merino Andrea Facskó Luís Fígueira Alejandro Fonollosa Éric Fortin Richard Gale Mauro Galeazzi Sandra García José María García Ruiz de Morales Nataša Gašperšič Debra A. Goldstein Marta Guedes Yan Guex‐Crosier Ahmet Gül Rola N. Hamam Muhammad Haroon Kenichi Hasegawa Arnd Heiligenhaus Claire Hooper Yih‐Shiou Hwang De‐Kuang Hwang Xavier Juanola Toshikatsu Kaburaki Sibel Kadayıfçılar John H. Kempen Takeshi Kezuka Amin Kherani Maarja Kirsimäe Kaisu Kotaniemi Aleksandra Kraut Agnieszka Kubicka‐Trząska Lucia Kuffová Susan Lightman Lyndell L. Lim Wee Kiak Lim Peter McCluskey Mairide McGuire Pierfrancesco Mirabelli Elisabetta Miserocchi Marta Misiuk‐Hojło Cristina Muccioli Santiago León Atehortúa Muñoz Conor C. Murphy Philip I. Murray Zoltán Zsolt Nagy Kenichi Namba Piergiorgio Neri Quan Dong Nguyen Donncha O’Gradaigh Mohammed A. Omair Kati Otsa Yılmaz Özyazgan Franco Pablo Maria Pia Paroli Uwe Pleyer

An international, expert-led consensus initiative to develop systematic, evidence-based recommendations for the treatment of noninfectious uveitis in era biologics.The availability biologic agents human eye disease has altered practice patterns management uveitis. Current guidelines are insufficient assure optimal use noncorticosteroid systemic immunomodulatory agents.An international expert steering committee comprising 9 specialists (including both ophthalmologists and rheumatologists)...

10.1016/j.ophtha.2017.11.017 article EN cc-by-nc-nd Ophthalmology 2018-01-06

To assess the effect of gastrointestinal (GI) manifestation on quality life in patients with systemic sclerosis (SSc).The University California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2 questionnaire was completed by 87 consecutive SSc attending scleroderma clinic at a single center. Their clinical features and current therapies were recorded; 100 rheumatologic disorders other than used as controls. Individual scores compared between controls, subgroups.Of...

10.3899/jrheum.110826 article EN The Journal of Rheumatology 2012-04-01

Abstract Aim The dynamics of coronavirus disease 2019 (COVID‐19) pandemic has become special concern to the rheumatology community. Rheumatic patients are required engage in effective health management but their behavior is often influenced by intrinsic and extrinsic factors. This cross‐sectional study aims examine patients’ experiences during current its implication on perception behavior. Method A patient‐centered electronic survey was used, randomly sampling rheumatic Saudi Arabia March...

10.1111/1756-185x.13959 article EN International Journal of Rheumatic Diseases 2020-09-17

Introduction Medication non-adherence is an important cause of treatment failure among patients with systemic lupus erythematosus (SLE). Depression a common neuropsychiatric disorder associated SLE. The aims this study are to assess the prevalence both medication and depressed mood Saudi SLE by using validated tools explore impact depressive symptoms disease activity on non-adherence. Methods A cross-sectional was conducted in outpatients assessed Morisky Adherence Scale, severity evaluated...

10.1177/0961203317725585 article EN Lupus 2017-08-21

Purpose: This study aimed to assess patient activation using measure 13 (PAM-13) in systemic lupus erythematosus (SLE), psoriatic arthritis (PsA), and axial spondyloarthritis (axSPA). Patients methods: A cross-sectional was conducted involving patients with three rheumatological conditions (SLE, PsA, axSPA). were contacted either at the clinic or through social media platforms. Data, including demographics, PAM 13, Arabic compliance questionnaire for rheumatology (ACQR), disease-related...

10.3390/healthcare13010071 article EN Healthcare 2025-01-02

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a heterogeneous group of rare, autoimmune conditions characterized by widespread, multisystemic inflammation small to medium-sized blood vessels. We present case report 46-year-old male with history prior ischemic strokes and recurrent bilateral non-granulomatous panuveitis associated strongly positive anti-neutrophil (c-ANCA) titer. Initial treatment steroids, methotrexate, rituximab were ineffective, but the...

10.1186/s12348-025-00454-0 article EN cc-by Journal of Ophthalmic Inflammation and Infection 2025-02-20

BACKGROUND Multiple autoimmune syndromes are caused by immune dysregulation pathways and shared genetic polymorphisms, resulting in the coexistence of multiple disorders. Systemic sclerosis (SSc) systemic lupus erythematosus (SLE) connective tissue diseases with distinct pathogenesis. Celiac disease (CD) is an immune-mediated small intestine pathology. Previous case reports have documented SLE CD, SSc (overlap syndrome). CASE REPORT A 21-year-old woman juvenile interstitial lung was admitted...

10.12659/ajcr.945176 article EN cc-by-nc-nd American Journal of Case Reports 2025-02-19

Medication preferences and associated challenges remain unexplored in Saudi patients with rheumatoid arthritis (RA). To explore the perceptions, beliefs experiences of RA regarding disease its treatment Arabia. Three focus groups were created Riyadh, Arabia through purposeful sampling. Discussions recorded transcribed. Subsequently, thematic analysis was performed. The included women, aged 35-50 years (n=6), men (n=4) women above 50 (n=5). identified themes stress losing a loved one as...

10.1136/bmjopen-2024-084057 article EN cc-by-nc-nd BMJ Open 2025-03-01

It has been hypothesized that adaptation of health practice guidelines to the local setting is expected improve their uptake and implementation while cutting on required resources. We recently adapted published American College Rheumatology (ACR) Rheumatoid Arthritis (RA) treatment guideline Eastern Mediterranean Region (EMR). The objective this paper describe process used for 2015 ACR RA EMR. GRADE-Adolopment methodology process. in detail how adolopment enhanced efficiency following steps...

10.1186/s12955-017-0754-1 article EN cc-by Health and Quality of Life Outcomes 2017-09-21

Though biologic agents have significantly improved the treatment of inflammatory arthritis (rheumatoid arthritis, psoriatic and axial spondyloarthritis), high costs, stringent regulations, strict reimbursement criteria, existing patents limited patient access to treatments. While being highly similar in quality, safety, efficacy reference products, biosimilars can reduce financial burden prevent underutilization medication. The objective this initiative was develop an evidence-based...

10.1007/s40259-023-00642-1 article EN cc-by-nc BioDrugs 2024-02-25

Background: Fibromyalgia (FM), a complex neurological disorder, has multiple consequences for the patient. To diagnose patients, healthcare practitioners use diagnostic questionnaires. However, Arabic translated or validated tools are lacking. This study aimed to translate and validate Rapid Screening Tool (FiRST) into language. Methods: Forward backward translations of FiRST were conducted by two translators English-certified translators. The survey was piloted (n = 5) subjected cognitive...

10.3390/healthcare11070961 article EN Healthcare 2023-03-28

The use of complementary and alternative medicine (CAM) is unexplored among Saudi rheumatoid arthritis (RA) patients. aim this study was to estimate the prevalence types CAM used patients with RA factors associated their use.A cross-sectional conducted at rheumatology clinics in two tertiary hospitals located Riyadh, Arabia. data collected between May 2017 February 2018. Unpaired Student's t-tests, Chi-square tests, Pearson correlation tests were compare users vs nonusers.A total 438 (mean...

10.1016/j.jsps.2019.07.002 article EN cc-by-nc-nd Saudi Pharmaceutical Journal 2019-07-08

Abstract Abatacept, an inhibitor of CD28 mediated T-cell activation, has been shown to be effective in controlling inflammation during rheumatoid arthritis (RA). However, its effects on immune regulatory B and T cells (Bregs Tregs) not fully explored. Thirty-one RA patients treated with abatacept for ≥ 6 months along 31 other modalities as well 30 healthy controls were recruited. Of these 62 patient, 49 (79%) females a mean age 54 ± 12 years disease duration 10 years. The blood levels Tregs...

10.1038/s41598-021-83615-0 article EN cc-by Scientific Reports 2021-03-11

To explore the quality of life (QoL) patients with systemic lupus erythematosus (SLE) and factors affecting it.

10.15537/smj.2024.45.10.20240432 article EN Saudi Medical Journal 2024-10-01

The aim of the present study, is to investigate influence obesity, with and without polycystic ovarian syndrome (PCOS), on levels kisspeptin, vitamin D (Vit D), vascular endothelial growth factor (VEGF) explore relationship between these parameters endocrine metabolic variables. study group included 126 obese Saudi females. Of 63 were suffering from PCOS while rest normo-ovulatory women (non-PCOS obese). In PCOS, VEGF was almost four times as high in non-PCOS obese, kisspeptin Vit did not...

10.3389/fendo.2021.665446 article EN cc-by Frontiers in Endocrinology 2021-05-26
Coming Soon ...